We demonstrate that T cells redirected with TCRFLT3D/Y (TCRFLT3D/Y cells) specifically and efficiently eliminate primary human AML cells harboring FLT3D835Y in vitro and in vivo, while sparing cells expressing wild-type (WT) FLT3. The gene discussed is FLT3; the disease is acute myeloid leukemia.